Mari Kannagi
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 07, 2025
Elimination of residual adult T-cell leukaemia clones by Tax-targeted dendritic cell vaccine.Tadafumi Iino, Atsuhiko Hasegawa, Takaji Matsutani
|Feb 02, 2023
Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL responses.Atsuhiko Hasegawa, Megumi Murata, Tomoka Fujikawa
|Jan 07, 2021
Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.Miku Ishizawa, Undrakh Ganbaatar, Atsuhiko Hasegawa
|Aug 24, 2019
Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.Mari Kannagi, Atsuhiko Hasegawa, Yoshiko Nagano
|Jan 23, 2019
Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.Mari Kannagi, Atsuhiko Hasegawa, Yoshiko Nagano
|Sep 15, 2017
IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.Leila Sawada, Yoshiko Nagano, Atsuhiko Hasegawa
Pageof 1
